Biohaven Ltd. — Investor Relations & Filings
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas of focus are neuroscience, immunology, and oncology. Biohaven is advancing a portfolio of late- and early-stage drug development programs, building upon its legacy of success in transforming migraine treatment with Nurtec® ODT (rimegepant) and Zavzpret® (zavegepant). The company utilizes proprietary drug development platforms and combines internal research with intellectual property licensed from global institutions to address a broad range of rare and common diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | |
| 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41064217 | 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | ||
| 32990155 | 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | ||
| 32900526 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900525 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900527 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900528 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900529 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900530 | 8-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 32900531 | 10-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 13597694 | 8-K | 2026-01-12 | English | ||
| 13597695 | FORM 4 | 2026-01-08 | English | ||
| 13597697 | FORM 4 | 2026-01-08 | English | ||
| 13597696 | FORM 4 | 2026-01-08 | English | ||
| 13597698 | FORM 4 | 2026-01-08 | English | ||
| 13597699 | FORM 4 | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Biohaven Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31890/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31890 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31890 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31890 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31890}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biohaven Ltd. (id: 31890)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.